Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Filings indexed 752 across all filing types
Latest filing 2015-04-27 Share Issue/Capital Cha…
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
PCI Biotech: Mandatory notification of trade - exercise of employee share options
Share Issue/Capital Change Classification · 99% confidence The document explicitly states it is a 'Mandatory notification of trade - exercise of employee share options' involving a primary insider (CEO) and other employees. It details the exercise of options, the resulting increase in share capital, and the subsequent transfer/purchase agreements related to these shares. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it involves share capital changes, the core purpose is reporting insider transactions.
2015-04-27 English
PCI Biotech: Notice of Annual General Meeting 2015
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report 2014' for PCI Biotech Holding ASA. It contains a 'Board of Directors Report 2014', detailed descriptions of company technology, clinical trial progress, and business operations for the fiscal year 2014. It is a comprehensive report rather than a short announcement or certification, fitting the definition of a 10-K (Annual Report). FY 2014
2015-04-20 English
PCI Biotech: Notice of Annual General Meeting 2015
AGM Information Classification · 100% confidence The document text explicitly uses the Norwegian phrase 'INNKALLING TIL ORDINÆR GENERALFORSAMLING' which translates to 'NOTICE OF ORDINARY GENERAL MEETING'. The content details the time, place, proposed agenda items (including election of board members, approval of accounts, and remuneration), and procedures for shareholder participation and proxy voting. This content perfectly matches the definition of materials shared for an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2015-04-20 English
PCI Biotech: Notice of Annual General Meeting 2015
Board/Management Information Classification · 98% confidence The document is titled 'Proposal from the Nomination committee of PCI Biotech Holding ASA' and details the committee's work, proposed re-elections and new appointments for the Board of Directors, and proposed remuneration for both the board and the nomination committee. This content directly relates to the composition and governance structure of the board, which aligns perfectly with the definition of Board/Management Information (MANG) or Governance Information (CGR). Since the primary focus is on proposing changes to the Board of Directors (management/governance structure) ahead of a shareholder meeting, MANG is a strong fit, as is CGR. However, the specific focus on the Nomination Committee's proposal for board members and their compensation is a key component of corporate governance reporting, often preceding an AGM. Given the options, 'Board/Management Information' (MANG) captures the essence of proposing board composition changes. If the document were solely about general rules or structure, CGR would be better, but this is a specific proposal for personnel changes. It is not a full Annual Report (10-K), an Earnings Release (ER), or a proxy statement (PSI). MANG is the most precise fit for a proposal regarding board composition and director remuneration.
2015-04-20 English
PCI Biotech: Notice of Annual General Meeting 2015
Remuneration Information Classification · 98% confidence The document is titled "Styrets erklæring om fastsettelse av lønn og annen godtgjørelse for ledende ansatte" (Board's statement on determination of salary and other remuneration for senior management) and explicitly states it is prepared in accordance with Norwegian Public Limited Companies Act § 6-16a and presented to the general meeting. It details policies regarding salary, benefits, bonus, options, pension, and severance for senior management. This content directly corresponds to the definition of Remuneration Information, which maps to the filing code DEF 14A (Proxy Solicitation & Information Statement, which often includes remuneration reports, or more specifically, the content aligns with the concept of executive compensation disclosure required in various jurisdictions, often bundled with proxy materials or specific compensation reports). Given the specific focus on executive compensation and remuneration policy disclosure, DEF 14A is the most appropriate fit among the provided options, as it covers compensation details often found in proxy statements.
2015-04-20 English
PCI Biotech: Notice of Annual General Meeting 2015
AGM Information Classification · 99% confidence The document is explicitly titled 'PCI Biotech: Notice of Annual General Meeting 2015' and invites shareholders to attend the AGM on May 12, 2015. It mentions that several documents, including the 'Notice of Annual General Meeting', 'executive remuneration statement', and 'The Annual Report', are attached or available. Since the document itself is the formal notice and invitation for the AGM, and it is very short (1180 chars), it fits the definition of AGM Information (AGM-R) better than a general Report Publication Announcement (RPA), as the primary purpose is to convene the meeting. The presence of the notice itself confirms this classification.
2015-04-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.